Back to Search
Start Over
Topical ozone therapy restores microbiome diversity in atopic dermatitis
- Source :
- International immunopharmacology. 80
- Publication Year :
- 2019
-
Abstract
- Staphylococcus aureus (S. aureus) accounts for 90% of the microbiome in atopic dermatitis (AD) lesions and plays a role in disease flare-ups and worsens disease outcome. Ozone treatment can improve AD conditions by its bactericidal effect on S. aureus.To study the effects of topical ozone therapy on microbiome diversity in AD lesions and explore potential probiotic pathogens correlated with AD progression.Patients with moderate to severe bilateral skin lesions in AD were recruited. Randomized split sides were performed. One side was treated with ozone hydrotherapy followed by ozonated oil; while the contralateral side with tap water and basal oil. Patients' SCORAD scores and modified EASI were recorded before and after treatments. The microbiological compositions in targeting sites were determined using 16S rDNA sequencing.After three-day ozone therapy, patients showed a significant decrease in SCORAD scores and inflammatory cell infiltration in AD lesions. The micro-ecological diversity was higher in the non-lesional as compared with lesional areas (p 0.05), which was also negatively correlated with the severity of AD (r = -0.499, p 0.05). The proportion of S. aureus in AD lesions was positively correlated with the severity of AD (r = 0.564, p = 0.010), which was decreased after ozone treatment (p = 0.07). Ozone therapy showed an increase in microbiological diversity with a significant increase in the proportion of Acinetobacter (p 0.05).Topical ozone therapy is highly effective for treatment for AD. It can change the proportional ratio of Staphylococcus and Acinetobacter, thereby restoring the microbiological diversity in AD lesions.
- Subjects :
- 0301 basic medicine
Adult
DNA, Bacterial
Male
medicine.medical_specialty
Staphylococcus aureus
Adolescent
Administration, Topical
Immunology
medicine.disease_cause
Gastroenterology
Severity of Illness Index
law.invention
Dermatitis, Atopic
03 medical and health sciences
Basal (phylogenetics)
Probiotic
Young Adult
0302 clinical medicine
Ozone
law
Internal medicine
RNA, Ribosomal, 16S
Immunology and Allergy
Medicine
Humans
Microbiome
SCORAD
Child
Hydrotherapy
Skin
Pharmacology
medicine.diagnostic_test
Acinetobacter
business.industry
Microbiota
Probiotics
Atopic dermatitis
medicine.disease
Ozone therapy
030104 developmental biology
Treatment Outcome
030220 oncology & carcinogenesis
Female
business
Staphylococcus
Subjects
Details
- ISSN :
- 18781705
- Volume :
- 80
- Database :
- OpenAIRE
- Journal :
- International immunopharmacology
- Accession number :
- edsair.doi.dedup.....e5c6903b0020aad2fe4b42f16c56e447